99mTc-Alafosfalin: An antibiotic peptide infection imaging agent

Nuclear Medicine and Biology

Volumn 30, Issue 2, 2003, Pages 169-175

  Tsopelas, C ^a   Penglis, S ^a   Ruszkiewicz, A ^b   Bartholomeusz, F D L ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

99mTc leukocytes; Alafosfalin; Antibiotic peptide; Infection imaging

Indexed keywords

ALAFOSFALIN; ALAFOSFALIN TC 99M; ANTIBIOTIC AGENT; LEUKOCYTE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; STANNOUS FLUORIDE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; ALANINE; ANTIINFECTIVE AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PEPTIDE; TECHNETIUM; TECHNETIUM 99M ALAFOSFALIN; TECHNETIUM COMPLEX;

ABDOMINAL INFECTION; ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL LABELING; COLLOID; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG BINDING; DRUG BONE LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG LIVER LEVEL; DRUG PURITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; INJECTION; ISOTOPE LABELING; NONHUMAN; QUANTITATIVE ANALYSIS; RADIOCHEMISTRY; RAT; SCINTIGRAPHY; SOFT TISSUE INFECTION; SPLEEN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; URINARY EXCRETION; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; COMPARATIVE STUDY; EVALUATION; LEUKOCYTE; METABOLISM; MYOSITIS; PATHOLOGY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; VALIDATION STUDY; WHOLE BODY COUNTING;

ALANINE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; LEUKOCYTES; MYOSITIS; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; TECHNETIUM; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

EID: 0037291711     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00348-7     Document Type: Article

References (32)

1. Atherton F.R., Hall M.J., Hassall C.H., et al. Phosphonopeptides as antibacterial agents rationale, chemistry, and structure-activity relationships . Antimicrob. Agents & Chemother. 15:(5):1979;677-683.
2. Atherton F.R., Hall M.J., Hassall C.H., et al. Phosphonopeptides as antibacterial agents alaphosphin and related phosphonopeptides . Antimicrob. Agents & Chemother. 15:(5):1979;684-695.
3. Atherton F.R., Hall M.J., Hassall C.H., et al. Phosphonopeptides as antibacterial agents mechanism of action of alaphosphin . Antimicrob. Agents & Chemother. 15:(5):1979;696-705.
4. J.W. Babich, H. Solomon, M.C. Pike, et al., Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection, J. Nucl. Med. 34 (1993) 1964-1974.
5. 99mTc leucocytes labelled by stannous colloid phagocytosis. In: M Nicolini, G. Bandoli, U. Mazzi (Eds.), Technetium and rhenium in chemistry and nuclear medicine 3, Cortina International, Verona: Italy, pp. 741-748.
6. W. Becker, W. Borst, W. Fischbach, et al. Kinetic data of in vivo labelled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody, Eur. J. Nucl. Med. 15 (1989) 361-366.
7. 99mTc-radiopharmaceuticals, Aust. NZ J. Med. 14 (1984) 945-946.
8. Bevan J., Tofe A.J., Benedict J.J., et al. Tc-99m HMDP (hydroxyethylene diphosphonate) a radiopharmaceutical for skeletal and acute myocardial infarct imaging. 1. Synthesis and distribution in animals . J. Nucl. Med. 21:1980;961.
9. K.E. Britton, S. Vinjamuri, A.V. Hall, et al. Clinical evaluation of technetium-99m for the localisation of bacterial infection, Eur. J. Nucl. Med. 24 (1997) 553-556.
10. 99mTc human immunoglobin (HIG) - first results of a new agent for the localisation of infection and inflammation, Eur. J. Nucl. Med. 16 (1990) 649-655.
11. Dass S. S., Britton K. E., Solanki K, K., et al. [Letter to the Editor] Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations, Eur. J. Nucl. Med. 27 (12) (2000) 1865-1866.
12. Ellis B.L., Sharma H.L. Co, Fe and Ga chelates for cell labelling a potential use in PET imaging? Nucl. Med. Commun. 20:1999;1017-1021.
13. Fischman A. J., Babich J. W., Rubin R, H., et al. Infection imaging with technetium-99m-labeled chemotactic peptide analogs, Semin. Nucl. Med. 2 (1994) 154-168.
14. R.W. Hanna, F.E. Lomas, Identification of factors affecting technetium 99m leucocyte labelling by phagocytic engulfment and development of an optimal technique, Eur. J. Nucl. Med. 12 (1986) 159-162.
15. R.J. Kowalsky, J.R. Perry, Radiopharmaceuticals in Nuclear Medicine Practice, Appleton-Lange, Connecticut: USA, 1987, pp. 289-291.
16. 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole, Nucl. Med. Comm. 21 (2000) 573.
17. Nibbering P.H., Welling M.M., van der Broek P.J., et al. Radiolabelled antimicrobial peptides for imaging of infections a review . Nucl. Med. Commun. 19:1998;1117-1121.
18. 99mTc-labelled ciprofloxacin for infection detection. Concerns about radiolabelled antimicrobial peptides for infection detection, Eur. J. Nucl. Med. 27 (12) (2000) 1866-1868.
19. Pauwels E.K.J., Welling M.M., Paulusma-Annema A., et al. Radiolabelled antimicrobial peptides for imaging of infections. [Abstract] Nucl. Med. Commun. 21:2000;593.
20. 99mTc-Phosphomycin for the localisation of bacterial infection, Hellenic J. Nucl. Med. 4 (3) (2001) 161-164.
21. 99mTc]HMPAO-leukocytes for imaging infection, Semin. Nucl. Med. 2 (1994) 110-127.
22. 2: an investigation of the labelling process by autoradiography, Eur. J. Nucl. Med. 22 (1995) 101-107.
23. 99mTc-human serum albumin (HAS) in rat model, J. Nucl. Med. 41(Supplement) (2000) 322P.
24. Rubin R.H., Fischman A.J. The use of radiolabeled non-specific immunoglobulin in the detection of focal inflammation. Semin. Nucl. Med. 2:1994;169-179.
25. M. deSchrijver, K. Streule, R. Senekoasteh, Scintigraphy of inflammation with nanometer sized colloidal tracers, Nucl. Med. Comm. 8 (1987) 895-908.
26. ®. Nucl. Med. Commun. 22:2001;513-519.
27. m-alafosfalin: a potential new antibiotic peptide for imaging bacterial infection, Nucl. Med. Commun. 21 (5) (2000) 477.
28. 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection, The Lancet 347 (1996) 233-235.
29. 99mTc-labeled human neutrophil peptide-1, J. Nucl. Med. 40 (1999) 2073-2080.
30. Welling M.M., Paulusma-Annema A., van den Barselaar E.K.J., et al. Radiolabelled antimicrobial peptides distinguish between infections and inflammatory processes. [Abstract] Nucl. Med. Commun. 21:2000;582.
31. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections, J. Nucl. Med. 42 (5) (2001) 788-794.
32. M.M. Welling, S. Mongera, A. Lupetti, H.S. Balter, V. Bonetto, U. Mazzi, E.K. Pauwels, P.H. Nibbering, Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections, Nucl. Med. Biol. 29 (4) (2002) 413-422.